Search for: "In Re: Fosamax v." Results 61 - 80 of 107
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Feb 2013, 9:42 am by Bexis
  If so, you’re already one up on Arters. [read post]
7 Nov 2014, 5:52 am
Parke, Davis & Co., 256 F.3d 1013, 1021 (10th Cir. 2001) (wrong to “construe [a treater’s] ‘heeding’ an adequate warning to mean [s/he] would have given the warning”) (applying Oklahoma law); In re Diet Drug Litigation, 895 A.2d 480, 490-91 (N.J. [read post]
8 Jan 2019, 6:32 am by Elizabeth McCuskey
The Supreme Court opened its January session Monday morning with argument in Merck Sharp & Dohme Corp. v. [read post]
24 May 2010, 3:13 am by Sean Wajert
June 20, 2000); see also In re Fosamax Products Liab. [read post]
2 Sep 2010, 1:16 pm by Bexis
  In re Fosamax Products Liability Litigation, 2008 WL 2940560, at *7 (S.D.N.Y. [read post]
25 Jan 2012, 2:27 pm by Michelle Yeary
” In re Fosamax Products Liability Litigation, 742 F. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
16 May 2012, 12:22 pm by Bexis
April 20, 2012) (PMA preemption case); Reed, 2012 WL 859729, at *5; In re Fosamax Products Liability Litigation, 2011 WL 5903623, at *5 (D.N.J. [read post]
6 Mar 2014, 12:41 pm
  Accord In re Fosamax Alendronate Sodium Products Liability Litigation, 2013 WL 1558697, at *7-8 (D.N.J. [read post]
31 Dec 2014, 5:00 am
  We hope that your 2014 was pleasant and (if you’re on our side of the “v. [read post]
26 May 2015, 7:42 am
  So far many plaintiffs have had trouble coming up with factual support to back such allegations – and sometimes we’re not even sure why they’re making them. [read post]
2 Dec 2011, 2:00 pm by Bexis
  In re Medtronic, Inc., Sprint Fidelis Leads Products Liability Litigation, 623 F.3d 1200, 1206 (8th Cir. 2010); Fosamax, 2011 WL 5903623, at *5; Wamsley v. [read post]
31 Aug 2010, 10:01 pm by Kelly
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus… [read post]